Cardiopulmonary effects of butorphanol tartrate in horses.

This study examines the effects of Butorphanol tartrate, an opioid-like pain medication, on the heart and lungs of healthy adult horses. The researchers found that doses of Butorphanol didn’t significantly affect most cardiopulmonary measurements or behaviors, but higher doses led to varied and primarily excitatory behavioral changes.

Overview of Study

• The study was designed to evaluate the cardiopulmonary and behavioral effects of Butorphanol tartrate in adult horses. Butorphanol tartrate, a type of analgesic medicine, was administered intravenously to horses in doses of 0.1, 0.2, and 0.4 mg per kilogram of body weight.
• The same horses were used during the research, and they were given the three separate doses on different occasions. The aim was to see if the medication had any major impacts on important facets of their cardiopulmonary function.

Results of the Study

• No significant alterations were observed in terms of heart rate, mean and diastolic arterial pressure, mean and diastolic pulmonary arterial blood pressure, or cardiac output in the horses subjected to the given doses.
• The only significant increase, considering a 0.05 level of significance, was noticed in the systolic arterial blood pressure of horses when they were given a dose of 0.2 mg/kg.
• Upon analyzing electrocardiographic intervals, respiratory rates, arterial blood gas values or pH, researchers did not record any significant changes that would be considered statistically notable.
• The study also notes that excitatory behavioral changes were observed with increasing doses of Butorphanol, although these effects varied from horse to horse.

Conclusion

• Overall, the study provides an important reference for equine practitioners considering using Butorphanol tartrate as it doesn’t seem to vastly influence the cardiopulmonary parameters. It showed that the drug’s administration even at higher doses did not have significant adverse effects on the horse’s heart rate, arterial pressure, or pulmonary arterial blood pressure, indicating its relative safety.
• However, practitioners should be aware of the potential for varied behavioral changes, especially excitatory ones, at higher levels of administration.